Teng C. Lee, M.D., F.A.C.S, joined UCSF as an Associate Professor of Surgery in the Division of Adult Cardiothoracic Surgery. He was previously the Co-Director of the Aorta Center at University of Florida. Prior to that, he founded the Center for Aortic Disease at University of Maryland and also started the highly successful Transcatheter Aortic Valve (TAVR) program there.

Originally from Singapore, he graduated from Washington University School of Medicine in Saint Louis. He then went on to a general surgery residency at Case Western Reserve University in Cleveland where he was also the Dudley P. Allen Scholar before finishing his cardiothoracic surgery residency at Duke University.

He also completed a fellowship in Endovascular/Interventional Radiology at Skåne University Hospital (Lund University) in Malmö, Sweden where he trained under the world-renowned Krassi Ivancev, M.D., Ph.D. and another fellowship in advanced aortic surgery, heart transplantation, and mechanical circulatory support at Duke University. Dr. Lee is one of only a handful of "hybrid" specialists fully cross-trained in both interventional and open surgical techniques for the treatment of complex thoracic aortic disease.

Dr. Lee's research is focused on new stent-graft technologies for the aortic arch. He had been the Site Principal Investigator in numerous clinical trials involving treatment of aortic arch aneurysms using minimally invasive (endovascular) techniques. He has experience in using branched stent-grafts in the aortic arch with the Gore Thoracic Branch Endoprosthesis, the Medtronic MonaLSA endoprosthesis, and the Cook 2-branch arch device.

Recently, he has also collaborated with bio-medical engineers to study the hemodynamic consequences of different stent-graft device in the aortic arch.

Over the last few years, Dr. Lee and his research collaborators have also been looking into the outcomes and management of acute type A aortic dissection, and potential strategies to improve them.